You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Brain cancers

Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

  • Technology appraisal guidance
  • Reference number: TA121
  • Published:  27 June 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 The technologies
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Appraisal Committee members, guideline representative and NICE project team
  • 8 Sources of evidence considered by the Committee
  • Appendix A WHO performance status classification
  • Update information

Update information

March 2014: Implementation section updated to clarify that carmustine implants and temozolomide are recommended options for treating newly diagnosed high-grade glioma.

ISBN: 978-1-4731-7067-4


Previous page Appendix A WHO performance status classification
Back to top